{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:13:37Z","timestamp":1778656417379,"version":"3.51.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1097\/md.0000000000006161","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T14:32:53Z","timestamp":1487773973000},"page":"e6161","source":"Crossref","is-referenced-by-count":9,"title":["Primary cutaneous diffuse large B cell lymphoma-other successfully treated by the combination of R-CHOP chemotherapy and surgery"],"prefix":"10.1097","volume":"96","author":[{"given":"Jinjing","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210309","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R2-18-20210309","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5070\/D34M58740V","article-title":"Diffuse large B-cell lymphoma","volume":"18","author":"Mundi","year":"2012","journal-title":"Dermatol Online J"},{"key":"R3-18-20210309","first-page":"12","article-title":"Primary cutaneous B-cell lymphomas","volume":"10","author":"Kempf","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"R4-18-20210309","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/ajh.24462","article-title":"Cutaneous B-cell lymphomas: 2016 update on diagnosis, risk-stratification, and management","volume":"91","author":"Wilcox","year":"2016","journal-title":"Am J Hematol"},{"key":"R5-18-20210309","first-page":"589","article-title":"Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment","volume":"147","author":"Paulli","year":"2012","journal-title":"G Ital Dermatol Venereol"},{"key":"R6-18-20210309","doi-asserted-by":"crossref","first-page":"876","DOI":"10.5858\/arpa.2012-0195-RA","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations","volume":"136","author":"Hristov","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"R7-18-20210309","first-page":"83","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview","volume":"102","author":"Sabattini","year":"2010","journal-title":"Pathologica"},{"key":"R8-18-20210309","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/DAD.0b013e3181c1195b","article-title":"Primary cutaneous large B-cell lymphoma shows activation of nuclear factor kappa B and low incidence of Epstein\u2013Barr virus","volume":"32","author":"Bhagavathi","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"R9-18-20210309","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2141.2011.08702.x","article-title":"Co-infection of human herpesvirus-6 and human herpesvirus-8 in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"155","author":"Nakayama-Ichiyama","year":"2011","journal-title":"Br J Haematol"},{"key":"R10-18-20210309","first-page":"174","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type, with multiple local relapses: case presentation and brief review of literature","volume":"17","author":"Patsatsi","year":"2013","journal-title":"Hippokratia"},{"key":"R11-18-20210309","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2230.2009.03293.x","article-title":"Methotrexate-induced primary cutaneous diffuse large B-cell lymphoma with an \u201cangiocentric\u201d histological morphology","volume":"35","author":"Pfistershammer","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"R12-18-20210309","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4103\/0378-6323.77473","article-title":"Primary cutaneous diffuse large B cell lymphoma, leg type","volume":"77","author":"Dongre","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R13-18-20210309","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jaad.2015.02.1134","article-title":"Atypical clinicopathologic presentation of primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"72","author":"Massone","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R14-18-20210309","first-page":"93","article-title":"An 88-year-old woman with an ulcerous tumour on the leg. Primary cutaneous diffuse large-B-cell lymphoma, leg type","volume":"74","author":"Atiq","year":"2016","journal-title":"Neth J Med"},{"key":"R15-18-20210309","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/0970-1591.126912","article-title":"Ureteral spread of a primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"30","author":"Salem","year":"2014","journal-title":"Indian J Urol"},{"key":"R16-18-20210309","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12185-014-1728-2","article-title":"Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea","volume":"101","author":"Kim","year":"2015","journal-title":"Int J Hematol"},{"key":"R17-18-20210309","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jaad.2013.06.011","article-title":"Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification","volume":"69","author":"Su\u00e1rez","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R18-18-20210309","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaad.2011.03.031","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features","volume":"66","author":"Muniesa","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R19-18-20210309","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1600-0609.2005.00414.x","article-title":"Effective in vivo purging with rituximab and autologous peripheral blood stem cell transplantation in a woman with CD5 positive primary cutaneous diffuse large B-cell lymphoma","volume":"74","author":"Goto","year":"2005","journal-title":"Eur J Haematol"},{"key":"R22-18-20210309","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2013.07.019","article-title":"Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience","volume":"87","author":"Hamilton","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-18-20210309","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1346-8138.2006.00088.x","article-title":"Complete remission of a primary cutaneous follicle-center cell lymphoma (EORTC criteria)\/diffuse large B-cell lymphoma (WHO criteria) by single first-line therapy with rituximab","volume":"33","author":"Nagasaka","year":"2006","journal-title":"J Dermatol"},{"key":"R24-18-20210309","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1684\/ejd.2009.0688","article-title":"Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy","volume":"19","author":"Posada Garc\u00eda","year":"2009","journal-title":"Eur J Dermatol"},{"key":"R25-18-20210309","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archdermatol.2009.345","article-title":"Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients","volume":"146","author":"Guyot","year":"2010","journal-title":"Arch Dermatol"},{"key":"R26-18-20210309","first-page":"753","article-title":"Rituximab for primary cutaneous diffuse large B-cell lymphoma-leg type","volume":"20","author":"Fenot","year":"2010","journal-title":"Eur J Dermatol"},{"key":"R27-18-20210309","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"key":"R28-18-20210309","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1309\/EDAL-R8HA-U3EL-T37D","article-title":"Primary cutaneous diffuse large B-cell lymphoma: a clinicopathologic study of 15 cases","volume":"117","author":"Hembury","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R29-18-20210309","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.0303-6987.2005.00298.x","article-title":"Expression of the bcl-6 and MUM1\/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study","volume":"2","author":"Sundram","year":"2005","journal-title":"J Cutan Pathol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000006161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T15:45:18Z","timestamp":1658677518000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201702240-00018"}},"subtitle":["A case report and review of literature"],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000006161","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}